N0147: a randomized phase III trial of oxaliplatin plus 5-fluorouracil/leucovorin with or without cetuximab after curative resection of stage III colon cancer.

Steven R. Alberts; Frank A. Sinicrope; Axel Grothey

doi:10.3816/CCC.2005.n.033

N0147: a randomized phase III trial of oxaliplatin plus 5-fluorouracil/leucovorin with or without cetuximab after curative resection of stage III colon cancer.

Steven R. Alberts, Frank A. Sinicrope, Axel Grothey

Research output: Contribution to journal › Article › peer-review

Original language	English (US)
Pages (from-to)	211-213
Number of pages	3
Journal	Clinical colorectal cancer
Volume	5
Issue number	3
DOIs	https://doi.org/10.3816/CCC.2005.n.033
State	Published - Sep 2005

ASJC Scopus subject areas

Oncology
Gastroenterology

Access to Document

10.3816/CCC.2005.n.033

Cite this

@article{3bd1a2e1de1f4910bca3fd1c1253af3e,

title = "N0147: a randomized phase III trial of oxaliplatin plus 5-fluorouracil/leucovorin with or without cetuximab after curative resection of stage III colon cancer.",

author = "Alberts, {Steven R.} and Sinicrope, {Frank A.} and Axel Grothey",

year = "2005",

month = sep,

doi = "10.3816/CCC.2005.n.033",

language = "English (US)",

volume = "5",

pages = "211--213",

journal = "Clinical Colorectal Cancer",

issn = "1533-0028",

publisher = "Elsevier",

number = "3",

}

TY - JOUR

T1 - N0147

T2 - a randomized phase III trial of oxaliplatin plus 5-fluorouracil/leucovorin with or without cetuximab after curative resection of stage III colon cancer.

AU - Alberts, Steven R.

AU - Sinicrope, Frank A.

AU - Grothey, Axel

PY - 2005/9

Y1 - 2005/9

UR - http://www.scopus.com/inward/record.url?scp=32944471170&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=32944471170&partnerID=8YFLogxK

U2 - 10.3816/CCC.2005.n.033

DO - 10.3816/CCC.2005.n.033

M3 - Article

C2 - 16197625

AN - SCOPUS:32944471170

SN - 1533-0028

VL - 5

SP - 211

EP - 213

JO - Clinical Colorectal Cancer

JF - Clinical Colorectal Cancer

IS - 3

ER -

N0147: a randomized phase III trial of oxaliplatin plus 5-fluorouracil/leucovorin with or without cetuximab after curative resection of stage III colon cancer.

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this